These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26235208)

  • 21. Multiparametric analysis from dynamic susceptibility contrast-enhanced perfusion MRI to evaluate malignant brain tumors.
    Abreu VS; Tarrio J; Silva J; Almeida F; Pinto C; Freitas D; Filipe JP
    J Neuroimaging; 2024; 34(2):257-266. PubMed ID: 38173078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma.
    Jo SW; Choi SH; Lee EJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
    Korean J Radiol; 2021 Aug; 22(8):1369-1378. PubMed ID: 33987994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI.
    Artzi M; Liberman G; Nadav G; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D
    J Neurooncol; 2016 May; 127(3):515-24. PubMed ID: 26754857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients.
    Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F
    Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
    Kolakshyapati M; Hashizume A; Ochi K; Ueno H; Kaichi Y; Takayasu T; Takano M; Karlowee V; Akiyama Y; Awai K; Maruyama H; Sugiyama K; Kurisu K; Yamasaki F
    World Neurosurg; 2019 Nov; 131():e226-e236. PubMed ID: 31349079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.
    Saha A; Peck KK; Lis E; Holodny AI; Yamada Y; Karimi S
    Spine (Phila Pa 1976); 2014 Nov; 39(24):E1433-40. PubMed ID: 25188594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of the apparent diffusion coefficient for the evaluation of the white matter to differentiate between glioblastoma and brain metastases.
    Miquelini LA; Pérez Akly MS; Funes JA; Besada CH
    Radiologia; 2016; 58(3):207-13. PubMed ID: 26655126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation?
    Hakyemez B; Yildirim N; Erdoğan C; Kocaeli H; Korfali E; Parlak M
    Neuroradiology; 2006 Oct; 48(10):695-702. PubMed ID: 16896907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
    Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
    Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation between primary central nervous system lymphoma and glioblastoma: a comparative study of parameters derived from dynamic susceptibility contrast-enhanced perfusion-weighted MRI.
    Nakajima S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Arakawa Y; Takagi Y; Miyamoto S; Togashi K
    Clin Radiol; 2015 Dec; 70(12):1393-9. PubMed ID: 26382744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
    Hsu YH; Ferl GZ; Ng CM
    Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: a positron emission tomographic study with magnetic resonance imaging comparison.
    Kamson DO; Mittal S; Buth A; Muzik O; Kupsky WJ; Robinette NL; Barger GR; Juhász C
    Mol Imaging; 2013; 12(5):327-37. PubMed ID: 23759373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses.
    Ng CS; Raunig DL; Jackson EF; Ashton EA; Kelcz F; Kim KB; Kurzrock R; McShane TM
    AJR Am J Roentgenol; 2010 Feb; 194(2):W134-40. PubMed ID: 20093564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.
    Huang BY; Kwock L; Castillo M; Smith JK
    Technol Cancer Res Treat; 2010 Aug; 9(4):327-37. PubMed ID: 20626199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing hypervascular and hypovascular metastases and normal bone marrow of the spine using dynamic contrast-enhanced MR imaging.
    Khadem NR; Karimi S; Peck KK; Yamada Y; Lis E; Lyo J; Bilsky M; Vargas HA; Holodny AI
    AJNR Am J Neuroradiol; 2012 Dec; 33(11):2178-85. PubMed ID: 22555585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques.
    van Dijken BRJ; van Laar PJ; Smits M; Dankbaar JW; Enting RH; van der Hoorn A
    J Magn Reson Imaging; 2019 Jan; 49(1):11-22. PubMed ID: 30561164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.
    Wang S; Kim S; Chawla S; Wolf RL; Zhang WG; O'Rourke DM; Judy KD; Melhem ER; Poptani H
    Neuroimage; 2009 Feb; 44(3):653-60. PubMed ID: 18951985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low conductivity on electrical properties tomography demonstrates unique tumor habitats indicating progression in glioblastoma.
    Park JE; Kim HS; Kim N; Kim YH; Kim JH; Kim E; Hwang J; Katscher U
    Eur Radiol; 2021 Sep; 31(9):6655-6665. PubMed ID: 33880619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2D and 3D texture analysis to differentiate brain metastases on MR images: proceed with caution.
    Béresová M; Larroza A; Arana E; Varga J; Balkay L; Moratal D
    MAGMA; 2018 Apr; 31(2):285-294. PubMed ID: 28939952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors.
    Shah AH; Kuchakulla M; Ibrahim GM; Dadheech E; Komotar RJ; Gultekin SH; Ivan ME
    World Neurosurg; 2019 Jan; 121():e836-e842. PubMed ID: 30312826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.